VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
DOXAmdocs Limited
$51.97$5.6B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksDOXCash Flow

Amdocs Limited (DOX) Cash Flow Statement

29Y historyFree accessUpdated daily

Free cash flow margin volatility remains a concern, as evidenced by the decline to 6.9% in 2026Q2 alongside a $137.3 million outflow in working capital.

DOX Cash Flow Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMSep'25Sep'24Sep'23Sep'22Sep'21Sep'20Sep'19Sep'18Sep'17Sep'16Sep'15Sep'14Sep'13Sep'12Sep'11Sep'10Sep'09Sep'08Sep'07Sep'06Sep'05Sep'04Sep'03Sep'02Sep'01Sep'00Sep'99Sep'98Sep'97
Cash from Operations792.85M749.1M724.43M822.63M756.72M925.81M658.14M656.38M557.25M636.11M620.23M772.62M709.26M670.55M514.07M535.49M685.2M519.16M483.62M424M429.22M381.75M344.4M381.97M412.28M337.99M287.59M152.3M66.5M25.9M
Operating CF Margin %-16.53%14.47%16.83%16.53%21.59%15.79%16.06%14.02%16.45%16.68%21.21%19.9%20.04%15.83%16.85%22.96%18.14%15.29%14.95%17.31%18.73%19.42%25.75%25.55%22.03%25.72%24.29%16.47%8.93%
Operating CF Growth %98.97%3.41%-11.94%8.71%-18.26%40.67%0.27%17.79%-12.4%2.56%-19.72%8.93%5.77%30.44%-4%-21.85%31.98%7.35%14.06%-1.22%12.43%10.84%-9.84%-7.35%21.98%17.52%88.83%129.02%156.76%-
Net Income546.5M567.77M496.32M542.96M549.5M688.37M497.84M479.45M354.4M436.83M409.33M446.16M422.12M412.44M391.37M346.67M343.91M326.18M378.91M364.94M318.64M288.64M234.86M168.88M-5.06M66.39M5.98M98.5M30.4M5.9M
Depreciation & Amortization206.36M195.44M193.07M195.7M224.53M208.83M198.41M205.77M207.39M214.88M211.79M174.79M162.77M140.78M159.61M181.48M195.94M198.12M192.94M164.99M117.9M93.83M100.88M97.45M309.82M282.63M155.36M30.6M29.1M8.4M
Stock-Based Compensation25.96M104.86M104.54M89.7M71.81M54.25M42.43M38.55M47.48M44.54M42.7M44.56M44.58M40.34M43.43M36.63M44.45M42.91M000000000000
Deferred Taxes42.14M20.29M-45.67M-60.21M-3.29M-50.6M30.24M-13.95M21.4M6.55M-2.31M-26.89M-6.51M12.48M-4.86M1.25M-22.23M16.25M1.11M-21.09M22.81M8.06M-11.27M4M-1.67M5.02M-1.2M-4M-2M-11.9M
Other Non-Cash Items98.67M4.09M6.17M3.34M-6.71M-224.14M144K737K1.32M-4.66M-6.51M-5.47M-2.9M1.9M-6.31M1.21M22.39M8.08M59.06M53.54M71.18M4.46M3.51M9.45M33.21M3.92M84.6M200K-1.4M1.8M
Working Capital Changes-121.94M-143.36M-30M51.14M-79.12M249.09M-110.93M-54.18M-74.74M-62.03M-34.77M139.46M89.2M62.6M-69.18M-31.74M100.74M-72.38M-152.97M-135.44M-98.07M-13.24M16.43M102.19M75.97M-19.96M42.85M26M10.6M21.7M
Change in Receivables-208K79.61M-104.41M3.46M-64.98M-69.05M134.58M6.59M-67.2M-41.08M-70.86M39.83M5.54M30M-106.55M38.06M-131.39M131.53M000000000000
Change in Inventory00000-7.36M-32.09M37.13M-48.82M-42.78M25.94M33.31M11.68M51.79M32.99M000000000000000
Change in Payables-40.46M-77.04M216.32M158.88M-83.93M122.22M-190.35M-60.04M25.35M72.05M59.98M63.89M73.95M-4.1M60.2M000000000000000
Cash from Investing-270.56M-2.06M-127.41M-224.5M-262.5M-329M-461.73M-86.76M-362.39M-185.31M-440.85M-379.65M-298.55M-297.13M-17.29M-221.67M-211.51M-66.38M-169.71M-441.28M-629.24M-126.16M-260.21M47.01M-653.63M-339.19M-2.67M-41.7M-25.7M-49.1M
Capital Expenditures-114.11M-103.95M-105.5M-124.36M-227.22M-210.44M-205.51M-128.09M-231.15M-133.39M-130.09M-120.5M-111.57M-106.72M-122.05M-109.78M-86.94M-83.33M-135.82M-166.43M-80.72M-71.37M-54.15M-62.41M-58.56M-91.89M-56.57M-42.2M-26.6M-49.1M
CapEx % of Revenue2.47%2.29%2.11%2.54%4.96%4.91%4.93%3.13%5.82%3.45%3.5%3.31%3.13%3.19%3.76%3.45%2.91%2.91%4.3%5.87%3.25%3.5%3.05%4.21%3.63%5.99%5.06%6.73%6.59%16.93%
Acquisitions-246.81M-86.32M-86.82M-121.82M-14.43M146.29M-249.36M-60.57M-355.14M-18.06M-283.45M-263.19M-180.54M-112.41M122.05M-162.96M-200.31M-65.89M-58.77M-90.72M-624.8M-262.25M-10.65M-30.98M-213.18M00000
Investments------------------------------
Other Investing18.21M18.21M5.32M-4.3M-8.53M-6.08M-6.1M615K-3.16M-29.94M-18.53M1.41M3.87M-2.8M-130.62M-18.08M22.01M994K2.65M3.83M4.27M5.83M4.43M2.53M-39.58M-10.23M53.9M500K900K0
Cash from Financing-555.18M-768.12M-771.02M-651.43M-629.9M-870.93M315.14M-516.77M-425.69M-569.85M-446.3M-460.66M-321.63M-238.38M-448.99M-518.64M-166.26M-442.87M-210.56M25.6M99.66M-98.39M-381.44M-48.04M-164.99M471.9M32.21M-50.8M-69.1M60.9M
Debt Issued (Net)250M0000-100M743.92M00-200M-20M10M10M0-50M49.12M199.38M-450.75M-717K-25K-7.92M-22.44M14.01M-58.44M-60.87M457.93M10.85M-93.3M78.9M-12.9M
Equity Issued (Net)-543.07M-530.05M-563.12M-489.52M-508.47M-590.94M-360.91M-398.06M-337.95M-253.01M-323.82M-454.02M-372.01M-367.06M-484.61M-624.24M-389.29M-20.01M-210.05M24.83M106.85M-75.95M-395.45M2.32M-104.12M13.97M21.36M42.5M330.6M91.7M
Dividends Paid-230.43M-224.39M-211.97M-199.46M-186.07M-177.47M-164.06M-147.62M-134.29M-121.5M-109.3M-100.79M-90.94M-84.01M00000000000000-478.7M-18M
Share Repurchases-556.13M-551.34M-563.12M-489.52M-508.47M-680M-360.91M-398.06M-419.23M-340.6M-413.42M-454.02M-372.01M-367.06M-484.61M-624.24M-389.29M-20.01M-247.63M-49.84M0-99.98M-407.53M0-109.28M00000
Other Financing-31.68M-13.68M4.07M37.55M64.64M-2.52M96.2M28.9M46.55M4.67M6.83M84.15M131.32M212.69M85.61M56.47M23.64M27.89M211K795K722K008.08M0000100K100K
Net Change in Cash-32.9M-21.09M-174M-53.3M-135.69M-274.12M511.56M52.85M-230.83M-119.05M-266.91M-67.7M89.08M135.03M47.79M-204.82M307.43M9.91M103.35M8.31M-100.36M157.2M-297.25M380.94M-406.34M470.7M317.13M59.8M-28.3M60.9M
Free Cash Flow678.74M645.14M618.93M698.27M529.5M715.37M452.63M528.29M326.1M502.72M490.15M652.12M597.69M563.82M392.02M425.71M598.25M435.83M347.8M257.57M348.5M310.38M290.26M319.56M353.71M246.1M231.02M110.1M39.9M-23.2M
FCF Margin %14.68%14.23%12.37%14.29%11.57%16.68%10.86%12.93%8.2%13%13.18%17.9%16.77%16.85%12.07%13.4%20.05%15.22%11%9.08%14.05%15.22%16.36%21.54%21.92%16.04%20.66%17.56%9.88%-8%
FCF Growth %12.76%4.23%-11.36%31.87%-25.98%58.05%-14.32%62%-35.13%2.56%-24.84%9.11%6.01%43.83%-7.92%-28.84%37.27%25.31%35.03%-26.09%12.28%6.93%-9.17%-9.66%43.73%6.53%109.82%175.94%271.98%-
FCF per Share6.325.775.435.894.345.593.403.852.273.413.244.163.703.462.312.282.932.101.581.151.591.431.321.451.611.081.060.550.25-0.12
FCF Conversion (FCF/Net Income)1.24x1.33x1.47x1.52x1.38x1.34x1.32x1.37x1.57x1.46x1.52x1.73x1.68x1.63x1.31x1.54x1.99x1.59x1.28x1.16x1.35x1.32x1.47x2.26x-81.46x5.09x48.11x1.55x2.21x4.39x
Interest Paid35.7M41.47M35.4M19.43M16.74M19.37M5.39M7.35M2.01M1.15M576K548K628K468K408K433K2.85M3.32M4.86M00000000000
Taxes Paid75.62M122.42M187.51M156.39M80.42M146.44M45.4M75.79M55.94M67.54M50.41M51.14M59.22M38.44M36.91M19.61M46.45M39.79M51.27M00000000000

Key Metrics

Growth RegimeContracting
ProfitabilityModerate
Balance SheetHealthy
Cash FlowMixed
Top Statement Risk

Carrier Capex Concentration Risk

Earnings Quality and Cash Conversion

According to quarterly financial data, the relationship between net income and operating cash flow has shown significant volatility, with the OCF/NI ratio dropping to 0.74 in 2026Q2, suggesting that reported earnings are not consistently translating into cash generation due to timing differences in project-based revenue recognition.

The divergence between net income and operating cash flow appears to be driven by the company's reliance on percentage-of-completion accounting, which can create temporary disconnects between profit recognition and actual cash receipts. Investors should monitor whether this trend of lower conversion persists, as it may indicate a buildup of unbilled receivables or delays in milestone payments from key carrier clients.

Free Cash Flow Margin Volatility

As reported in recent financial statements, Amdocs' free cash flow margins have fluctuated significantly, ranging from a low of 6.9% in 2026Q2 to a peak of 18.5% in 2025Q3, reflecting the inherent cyclicality of the firm's large-scale digital transformation projects and their impact on cash flow generation.

The contraction in FCF margins during the most recent quarter suggests that the company is facing headwinds in maintaining its historical cash efficiency. This volatility warrants further investigation into whether the current decline is a temporary byproduct of project timing or a more structural shift in the profitability of new managed services contracts.

Working Capital Dynamics and Efficiency

Based on reported figures, working capital changes have been a major source of cash flow instability, with a significant outflow of $137.3 million in 2026Q2, indicating that the company's cash cycle is highly sensitive to the timing of large-scale billing and collection cycles within its carrier client base.

The substantial swings in working capital suggest that Amdocs may be providing extended payment terms to its primary North American customers to secure long-term managed services agreements. This dynamic appears to place pressure on short-term liquidity, requiring management to maintain a disciplined approach to balance sheet management to offset these periodic cash outflows.

Capital Allocation and Shareholder Returns

Data from recent filings indicates that Amdocs continues to prioritize shareholder returns, with $138.3 million allocated to share repurchases in 2026Q2, even as operating cash flow has faced pressure, suggesting a commitment to capital return despite the current cyclical downturn in carrier-driven project demand.

The company's consistent use of cash for dividends and buybacks, despite the recent revenue contraction, appears to be a signal of management's confidence in the long-term durability of its cash flows. However, investors should monitor whether this level of capital deployment remains sustainable if the current trend of lower operating cash flow conversion continues.

DOX — Frequently Asked Questions

Quick answers to the most common questions about buying DOX stock.

How much cash does Amdocs Limited (DOX) generate from operations?

Amdocs Limited (DOX) generated $749.1M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.

What is Amdocs Limited's free cash flow?

Amdocs Limited (DOX) generated $645.1M in free cash flow in 2025. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.

What is Amdocs Limited's capital expenditure (CapEx)?

Amdocs Limited (DOX) spent $104.0M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.

How does Amdocs Limited distribute cash to shareholders?

In 2025, Amdocs Limited (DOX) returned $224.4M to shareholders via cash dividends and spent $551.3M on share repurchases. This shows the company's commitment to returning capital to its equity investors.